Provided by Tiger Trade Technology Pte. Ltd.

TriSalus Life Sciences Inc.

1.45
0.0000
Volume:25.00
Turnover:33.03
Market Cap:72.31M
PE:-0.72
High:1.45
Open:1.45
Low:1.45
Close:1.45
52wk High:5.00
52wk Low:0.4201
Shares:49.87M
Float Shares:49.87M
Volume Ratio:0.01
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0160
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
TriSalus Life Sciences Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.